ZA766097B - Blocked cholecalciferol derivatives - Google Patents

Blocked cholecalciferol derivatives

Info

Publication number
ZA766097B
ZA766097B ZA00766097A ZA766097A ZA766097B ZA 766097 B ZA766097 B ZA 766097B ZA 00766097 A ZA00766097 A ZA 00766097A ZA 766097 A ZA766097 A ZA 766097A ZA 766097 B ZA766097 B ZA 766097B
Authority
ZA
South Africa
Prior art keywords
blocked
cholecalciferol derivatives
cholecalciferol
derivatives
blocked cholecalciferol
Prior art date
Application number
ZA00766097A
Other languages
English (en)
Inventor
D Jacobus
S Yang
H Jones
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA766097B publication Critical patent/ZA766097B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA00766097A 1975-10-14 1976-10-13 Blocked cholecalciferol derivatives ZA766097B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62197675A 1975-10-14 1975-10-14

Publications (1)

Publication Number Publication Date
ZA766097B true ZA766097B (en) 1978-05-30

Family

ID=24492438

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00766097A ZA766097B (en) 1975-10-14 1976-10-13 Blocked cholecalciferol derivatives

Country Status (12)

Country Link
US (1) US4069321A (nl)
JP (1) JPS5268163A (nl)
AU (1) AU1842976A (nl)
BE (1) BE847223A (nl)
DE (1) DE2646240A1 (nl)
DK (1) DK457176A (nl)
ES (1) ES452198A1 (nl)
FR (1) FR2327790A1 (nl)
GB (1) GB1524418A (nl)
NL (1) NL7611274A (nl)
SE (1) SE7611261L (nl)
ZA (1) ZA766097B (nl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53147051A (en) * 1977-05-24 1978-12-21 Teijin Ltd 1alpha-hydroxy-24-dehydro-vitamin d3 and its preparation
US4145346A (en) * 1977-10-03 1979-03-20 Merck & Co., Inc. Preparation of 3β-hydroxy-27-norcholest-5-ene-25-one and intermediates thereof
US4224230A (en) * 1978-07-26 1980-09-23 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4229357A (en) * 1978-07-26 1980-10-21 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4263214A (en) * 1978-07-26 1981-04-21 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same
US4196133A (en) * 1979-03-05 1980-04-01 Wisconsin Alumni Research Foundation 24,24-Difluoro-25-hydroxycholecalciferol
US4201881A (en) * 1979-03-28 1980-05-06 Wisconsin Alumni Research Foundation 24,24-Difluoro-1α,25-dihydroxycholecalciferol
US4230626A (en) * 1979-07-30 1980-10-28 G. D. Searle & Co. 25-Halocholest-5-ene-3β,22-diols and esters thereof
US4230627A (en) * 1979-08-06 1980-10-28 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
US4287129A (en) * 1980-07-28 1981-09-01 Diamond Shamrock Corp. Synthesis of 1α-hydroxy-7-dehydrosteroids
DE3270978D1 (en) * 1981-07-17 1986-06-12 Duphar Int Res Method of preparing 1-alpha-hydroxyvitamin d and 1-alpha-hydroxy-previtamin d compounds, and adduct of a previtamin d or tachysterol compound with a suitable dienophile
US4634692A (en) * 1981-08-28 1987-01-06 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxy-24R-fluorocholecalciferol and 1α,25-dihydroxy-24S-fluorocholecalciferol
US4428946A (en) * 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
IL74264A (en) * 1984-02-08 1988-08-31 Hoffmann La Roche Preparation of calciferol derivatives,certain such novel compounds and pharmaceutical compositions containing them
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
US4929609A (en) * 1987-03-12 1990-05-29 Hoffmann-La Roche Inc. 25, 28-dihydroxyergocalciferol and 1,25,28-trihydroxyergocalciferol compositions thereof and their use in the treatment of hyperproliferative disease
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンd▲下3▼類固型製剤
US5401731A (en) * 1989-06-29 1995-03-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) Vitamin D analogues
KR100257445B1 (ko) * 1992-04-15 2000-08-01 에드워드 이. 데이비스 스테롤 혼합물로부터 5,7-디엔작용기를 함유한 스테로이드를 분리하는 방법
JP2905091B2 (ja) * 1994-06-24 1999-06-14 日本バルカー工業株式会社 フッ素樹脂被覆ガスケットの製造方法
KR100756823B1 (ko) * 2001-10-23 2007-09-07 주식회사 엘지생활건강 신규한 폴리에톡실화 콜레칼시페롤 유도체 및 그의 제조방법
US7795427B2 (en) * 2006-02-14 2010-09-14 New York University Methods for inhibiting osteoclast differentiation, formation, or function and for increasing bone mass
EP3965773A4 (en) * 2019-05-09 2024-02-21 Fermenta Biotech Limited NOVEL PROCESS FOR SYNTHESIS OF 25-OH CHOLESTEROL/CALCIFEDIOL FROM PHYTOSTEROL

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2862934A (en) * 1955-06-14 1958-12-02 Philips Corp Method of producing tachysterol and dihydrotachysterol
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
US3607888A (en) * 1969-08-07 1971-09-21 Wisconsin Alumni Res Found 25-hydroxytachysterol3 25-hydroxydihydrotachysterol3 and methods for preparing same

Also Published As

Publication number Publication date
FR2327790A1 (fr) 1977-05-13
FR2327790B1 (nl) 1979-07-20
JPS5268163A (en) 1977-06-06
DK457176A (da) 1977-04-15
SE7611261L (sv) 1977-04-15
NL7611274A (nl) 1977-04-18
AU1842976A (en) 1978-04-13
ES452198A1 (es) 1977-12-16
US4069321A (en) 1978-01-17
GB1524418A (en) 1978-09-13
BE847223A (fr) 1977-04-13
DE2646240A1 (de) 1977-04-28

Similar Documents

Publication Publication Date Title
ZA766097B (en) Blocked cholecalciferol derivatives
HK23979A (en) Piperidyl-triazine derivatives
GB1550160A (en) 4-hydroxypyrrolidin-2-one derivatives
GB1520812A (en) Benzhydrylsulphinyl derivatives
IL48209A0 (en) Amidinourea derivatives
IL49706A (en) Anhydro-vinca derivatives
AU1597876A (en) Ortho-aminobutyrophenone derivatives
AU1074176A (en) Oxadiazolinone derivatives
GB1540845A (en) 6-oxo-pyrimidine derivatives
IL59758A0 (en) -amino- , -bis-carobxy-alkane derivatives
HK25682A (en) Cis-bicyclooctyl-alkyl-amine derivatives
IE44308L (en) Androsten-17-one derivatives
GB1554720A (en) Pyridthione derivatives
JPS5248661A (en) 22methoxyybenzamide derivatives
JPS5248672A (en) Thiazolinylaminoopiperidine derivatives
GB1486104A (en) Phthalimidopiperidine derivatives
IL49102A0 (en) Triazolobenzocycloalkylthiadiazine derivatives
AU1661376A (en) Morphanthridine derivatives
GB1545577A (en) N-alkyl-3-phenylisoxazole-4-carboxamide derivatives
JPS5246057A (en) Dicaboxylacte derivatives
GB1520011A (en) Benodioxole derivatives
JPS5273892A (en) Azethizinone derivatives
IL49072A (en) Triazolocycloalkathiadiazine derivatives
GB1520682A (en) Monochloro-striazine derivatives
JPS51127096A (en) Triazorocycloalkylhydrothazine derivatives